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Based on modifications to enhance the a-helical structure of the broad spectrum antibiotic magainin 2, a series of ana- 
logues have been synthesized which display an increase up to two orders of magnitude in antimicrobial activity and, in 
the most favorable case, no appreciable increase in hemolytic activity over magainin 1 at the concentrations tested. 
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1. INTRODUCTION 
The observation that the African clawed frog 
Xenopus laevis, widely used for laboratory work, 
was remarkably free of infection in water filled 
with microbes after incisions through both skin 
and muscular layers of the abdomen into the 
peritoneum prompted the isolation of the active 
principles which permit infection-free wound heal- 
ing in this animal [l]. These principles consist of 
two peptides (denoted magainin 1 and 2) of 23 
amino acid residues differing at positions 10 and 
22. They inhibit growth of Gram-positive and 
Gram-negative bacteria and fungi and induce 
osmotic lysis of protozoa [ 1,2]. Magainin peptides 
were found to be identical with those which had 
earlier been isolated, characterized and named 
PGS peptides by Giovannini et al. [3]. 
Calculation of the potential for a-helix forma- 
tion by the Chou-Fasman principles [4] and projec- 
tion of the helix by the Schiffer-Edmundson 
method [5] revealed that the peptides might have 
amphiphilic a-helical structures that are important 
for their antimicrobial activity. Other polypeptides 
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with amphiphilic helical structures have been 
shown to interact with cell or organelle membranes 
[6-81. We report here synthesis of analogues with 
modifications designed to enhance the amphiphilic 
a-helical structures and demonstrate that they in- 
crease growth inhibitory activity toward a wide 
variety of microbes by between one and two orders 
of magnitude. 
2. EXPERIMENTAL 
2.1. Peptide synthesis and purification 
Magainin 1 and analogues of magainin 2 designated A, B, C, 
D, E, F, G and H whose sequences are shown in table 1 were 
synthesized by the standard Merrifield solid-phase method with 
benzhydrylamine resin and coupling procedures using sym- 
metric anhydrides or active esters of t-butyloxycarbonyl amino 
acids as described previously 191. Anhydrous HF cleavage of the 
peptides from the resin after completion of the synthesis was 
performed according to the previously described procedure [9]. 
Purification of the peptides was accomplished by Sephadex 
G-25 gel chromatography followed by reverse-phase HPLC on 
a Vydac C4, 300 A, 5 gm packing column with various eluting 
gradients composed of acetonitrile and 0.01 M trifluoroacetic 
acid. In all cases, amino acid composition revealed theoretical 
recoveries of all amino acids within experimental error and 
HPLC peak integration at 215 nm indicated >93% purity of 
the products. Magainin 2 was synthesized by Applied Bio- 
systems, Inc. (Foster City, California) and was purified as 
above. 
2.2. Circular dichroism 
CD spectra were measured in either 50 mM potassium phos- 
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phate buffer, pH 7.0, or 40% (vol/vol) trifluoroethanol 
(Sigma) in 50 mM potassium phosphate buffer, pH 7.0, on a 
Jasco model J-5000A spectropolarimeter with a cell path length 
of 5 mm. Two scans per sample were performed over the wave- 
length range 250-200 nm. A statistical computer program 
developed by Provencher [lo] was employed for the calculation 
of a-helical and P-sheet contents. 
2.3. Antimicrobial assay 
The antimicrobial activities of magainin peptides and 
analogues were assayed by procedures based on the macrodilu- 
tion method of Jones et al. [1 l] with modifications. Briefly, dif- 
ferent concentrations of peptides were added to 2 ml of tryp- 
ticase soy broth (BBL) containing the inocula of the test 
organisms adjusted to 10’ and IO6 CFU/ml. Microbial growth 
was determined by the increase in ODG~, after incubation of the 
tubes at 35°C for 6-9 h depending on the growth rate. The 
lowest concentration that resulted in complete inhibition of 
growth was recorded as the 100% minimal inhibitory concentra- 
tion. The 50% minimal inhibitory concentration was deter- 
mined from the plots of growth vs concentration of peptide. 
2.4. Erythrocyte hemolysis assay 
To 75 x 12 mm borosilicate test tubes containing a predeter- 
mined amount of dried peptide in duplicate, 2.5 ml of diluted 
human erythrocyte suspension (lo%, v/v) in isotonic phos- 
phate-buffered saline was added. After gentle mixing and in- 
cubation for 10 min at 37”C, tubes were centrifuged at 3000 x g 
for IO min. The supernatant was separated from cells and 
debris, diluted if necessary, and ODzso measured. 100% hemo- 
lysis was obtained by using 0.1% Triton X-100 [l]. 
3. RESULTS 
3.1. Magainin analogues 
From the examination of the primary sequences 
of magainin peptides elucidated in this laboratory 
[2] and that of Giovannini et al. [3], we have 
calculated by the Chou-Fasman principles [4] that 
magainins have a high potential for a-helix forma- 
tion. Projection of the helix by the Schiffer- 
Edmundson method revealed it to be amphiphilic. 
In order to enhance the helix formation, we 
modified low helical propensity residues of the se- 
quence at Gly13, Gly18 and Ser’ of the magainin 2 
peptide by substitution of Ala. As expected, the 
helical wheel diagram (fig.1) shows that the 
modified peptides maintain an amphiphilic profile 
very similar to that of the magainins. The magainin 
2 sequence was chosen because of its natural abun- 
dance and its higher antimicrobial activity than 
magainin 1 [2]. 
Modifications of the two termini by amidation 
of Ser23 and acylation of Gly’ with acetyl or ,&- 
alanyl were expected to stabilize the helical confor- 
Fig.1. @-Helical wheel diagram of magainin analogue B. The 
depth of shading corresponds with the hydrophilicity values 
assigned by Hopp and Woods [ 121. 
mation and to lower the susceptibility to exopep- 
tidase action. A D-Ala modification intended to 
disrupt stretches of helical structure, and thus to 
demonstrate the importance of that structure for 
the antimicrobial activity, was also performed. 
Table 1 shows amino acid sequences of magainin 1, 
2 and eight analogues designated A, B, C, D, E, F, 
G and H. 
3.2. Circular dichroic measurement 
CD of magainin 1, and 2, and four analogues, B, 
C, F and G, were measured in aqueous phosphate 
buffer and 40% trifluoroethanol between the range 
200 and 240 nm. The helical contents calculated 
from the CD spectra by the method of Provencher 
[lo] are summarized in table 2. It is apparent that 
both natural and modified peptides displayed no a- 
helix in the aqueous buffer. In the presence of 40% 
trifluoroethanol, all these peptides displayed an LY- 
helical conformation indicating that a conforma- 
tional change had occurred in a hydrophobic en- 
vironment . There is no concentration dependence 
for the spectra of analogues detected after two-fold 
dilution. The a-helical contents of the two natural 
peptides are 24 and 269’0, respectively, whereas the 
helical contents of the modified peptides are more 
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Peptide sequence of magainins and analogues 
Peptide Seauence 
Magainin 2 
Magainin 1 
A 
B 
C 
D 
E 
F 
G 
H 
1 5 10 15 20 23 
G-I-G-K-F-L-H-S-A-K-K-F-G-K-A-F-V-G-E-I-M-N-S 
All sequence modifications indicated are based on magainin 2. One letter amino acid abbreviation is used. ,8A, P-alanine; a, D-alanine 
than twice higher than those of the two natural preciable activity in all microorganisms tested in- 
peptides. The acetylation of Gly’ did not appear to dicating the conformational requirement for anti- 
enhance the helical conformation. microbial activity. 
3.3. Antimicrobial and hemolytic activities 
The antimicrobial activities of magainin peptides 
and analogues were assayed against Gram-positive 
and Gram-negative bacteria as described in section 
2. The determination of 100% inhibitory concen- 
tration appears to be more consistent among assays 
than that of 50% inhibitory concentration. The 
data of 50% inhibitory concentration are listed for 
the purpose of allowing further comparison of low 
potency magainin peptides and high potency 
analogues. As shown in table 3, analogues A, B, D, 
E, F, and G increased in antimicrobial activity be- 
tween one and two orders of magnitude over 
magainin 1 or 2. They clearly have the same spec- 
trum of activity as the naturally occurring peptides. 
The H analogue which contains D-Ala instead of 
L-Ala at three modification sites yielded no ap- 
Human erythrocyte hemolytic activity was 
measured for magainin 1 and analogues A, B, C, F, 
G and H in comparison with the hemolytic princi- 
ple, melittin, from honey bee venom. The result is 
illustrated in fig.2. Neither magainin 1 nor 
analogue H showed hemolytic activity at 
250 pg/ml of heparinized blood. At a peptide con- 
centration of 500,_~g/ml (not shown), analogue H 
did not cause hemolysis whereas magainin 1 show- 
ed only 3% hemolysis. However, the other 
analogues exhibited appreciable hemolysis at 
100 pg/ml which was approximately equivalent to 
l/100 the potency of melittin. Analogue G showed 
less than 1% hemolytic activity at 200 pug/ml. 
These results indicate that the hemolytic activity of 
the analogues generally increased in parallel to the 
increase of growth inhibitory activity except in the 
case of analogue G which showed high anti- 
Table 2 
Circular dichroism of magainins and representative analogues 
Peptides % structure calculated from CD spectra 
50 mM K-phosphate, pH 7 40% CF,CHzOH 
a-helix P-sheet c-helix p-sheet 
Magainin 1 0 44 24 37 
Magainin 2 0 46 26 38 
B 2 44 61 9 
C 0 48 61 14 
F 1 46 63 6 
G 2 43 52 17 
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Table 3 
Antimicrobial activity of magainin analogues 
Organism (ATCC no.) 50% and 100%” minimal inhibitory concentration bg/ml) 
Magainins Analogues 
1 2 A B C D E F G H 
Escherichia co/i 100 50 1.2 1.2 10 2.5 1.2 1.2 2.5 70 
(25922) 250 100 2.5 2.5 25 5 5 5 5 > 100 
Klebsiella pneumoniae 100 100 5 5 60 10 5 5 10 100 
(13883) 250 100 25 10 100 25 25 25 25 > 100 
Pseudomonas aeruginosa 430 >100 15 15 >100 25 25 25 25 100 
(27853) >500 >100 25 25 > 100 50 50 50 100 > 100 
Streptococcus agalaciiae 60 50 0.25 0.25 0.5 0.25 0.25 0.25 0.5 100 
(12386) 75 100 1 I 1 1 1 1 2.5 > 100 
Streptococcus faeealis 360 > 100 5 5 5 5 10 10 10 > 100 
(212) >500 >lOO 10 10 25 25 25 25 50 > 100 
Staphylococcus aureus 500 > 100 5 5 7.5 2.5 5 5 5 > 100 
(292 13) p-lactamase [+ ] > 500 >lOO IO 10 25 5 10 10 IO > 100 
Staphylococcus aureus 360 > 100 5 5 10 10 10 10 10 > 100 
(25923) p-lactamase [- ] >500 >I00 10 10 25 25 25 25 25 > 100 
a Minimal level of 100% inhibition is indicated in italics 
Magainins 1 and 2 are respectively synthetic. (>) Denotes no activity detected at the concentration indicated 
microbial activity but exceptionally low hemolytic 
activity. 
3.4. Structure and activities 
Omission of replacement at Ser’ reduced the an- 
timicrobial activity of analogues E, F, and G only 
slightly. These derivatives (F and G) also displayed, 
as mentioned above, a lower hemolytic activity 
which also increases their potential therapeutic 
value. Acetylation of the a-amino terminus 
Fig.2. Hemolytic activity of melittin, magainin 1 and analogues. 
(analogue C) significantly reduced the growth in- 
hibitory activity toward Gram-positive bacteria but 
the reduction toward Gram-negative bacteria (table 
3) was less despite the observation that the propor- 
tions of a-helical and apparent &sheet structures 
were identical to its non-acetylated counterpart 
(analogue B). Elongation or substitution with ,& 
alanine at the amino-terminus had no effect on 
either potency or specificity. These findings suggest 
that not only enhancement of the a-helical struc- 
ture is essential but also a free a-amino terminus is 
required to elicit the maxima1 antimicrobial ac- 
tivity. 
4. DISCUSSION 
Both natural [l] and synthetic [2] magainin pep- 
tides have been reported to be broad spectrum anti- 
microbial substances and to induce osmotic lysis of 
protozoa. Although the mechanism of action is not 
yet known, the potential of the magainin peptides 
to form an amphiphilic helical structure and their 
broad spectrum of activity led to the speculation 
that the peptides act on membrane function [l]. 
The importance of amphiphilic helices has been im- 
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plicated in a wide variety of biologically active 
polypeptides whose function is related to the bind- 
ing of lipids and cell membranes. Recent studies of 
the correlation of amphiphilic a-helical properties 
of apolipoproteins [6], melittin [7] and calcitonin 
[8] with their biological activities support this idea. 
In this report, we have shown that magainin pep- 
tides do not form a-helical structures in an aqueous 
buffer. Upon addition of a hydrophobic solvent, 
the peptides form Lu-helices. A recent study of the 
magainin 2 amide analogue using two-dimensional 
NMR spectroscopy [13] described the same find- 
ing. Replacements of low propensity amino acid 
residues with a high propensity Ala increase not 
only the a-helical contents, but also antimicrobial 
activities by one to two orders of magnitude. It 
should be pointed out that the 100% minimal in- 
hibitory concentration was employed in this study 
which is different from the previous study [2] in 
which the peptide concentration causing any 
growth suppression was considered as the end 
point. The fact that doubling of helix contents in- 
duced by 40% trifluoroethanol causes this remark- 
able increase in the antimicrobial activity is intrigu- 
ing. In the modification studies of calcitonin [S], 
although helical content was only one of the 
changed variables, an approximate doubling of 
helical content in either water of 50% aqueous 
trifluoroethanol resulted in a 2- to 3-fold increase 
in activity. Similar increases were obtained with 
corticotropin releasing hormone [ 141 though the 
degree of increase in helical content was not stated. 
NMR or Raman spectroscopic studies of the 
peptide-lipid interaction may clarify this question. 
Substitution of helix promoting residues at Gly13 
and Gly” seems to be the most important 
modification for increase in antimicrobial activity. 
Further substitution at Ser’, although it does not 
increase helical content or antimicrobial activity, 
does seem to increase hemolytic activity. Whether 
the magainin peptides can act through a signal 
transduction is not known. However, the Se? and 
Ser23 are potential sites for phosphorylation. It has 
been observed that replacement of Ser8 with Ala in 
this study and the removal of Ser23 [2] has little ef- 
fect on antimicrobial activity suggesting that phos- 
phorylation at these positions is not involved in the 
mechanism of action. The considerably lower 
hemolytic activity of the Ser* analogues may how- 
ever indicate a detoxification mechanism available 
466 
to mammalian cells through phosphorylation at 
this residue. Although acetylation of the amino- 
terminus generally favors stabilization of a-helical 
structure, the magainin analogue with acetylated 
amino-terminus displayed reduced antimicrobial 
activity suggesting that a free a-amino group pro- 
viding a positive charge appears to be required to 
maximize the activity. 
In conclusion, this new series of analogues ap- 
pears to be useful in the study of the structure- 
function relationship of magainins. In particular, 
studies of specificity toward various types of mem- 
brane by physico-chemical and biological ap- 
proaches are warranted. Because of the high anti- 
microbial potency demonstrated in the analogues, 
they should have a great value in the treatment of 
bacterial and fungal infections in man and 
domestic animals. 
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